Guanze Medical Information Industry (Holding) Co., Ltd.

  • Market Cap: N/A
  • Industry: Retailing
  • ISIN: KYG4315D1060
HKD
0.55
-0.03 (-5.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Sinco Pharmaceuticals Holdings Ltd.
Shanghai Haohai Biological Technology Co., Ltd.
Shanghai Pioneer Holding Ltd.
Meilleure Health International Industry Group Ltd.
IVD Medical Holding Ltd.
China Health Group Ltd.
Cryofocus Medtech (Shanghai) Co. Ltd.
Yestar Healthcare Holdings Co. Ltd.
Kingworld Medicines Group Ltd.
Tycoon Group Holdings Ltd.
Guanze Medical Information Industry (Holding) Co., Ltd.
Why is Guanze Medical Information Industry (Holding) Co., Ltd. ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Is Guanze Medical Information Industry (Holding) Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Guanze Medical Information Industry (Holding) Co., Ltd.
52.78%
-0.52
85.76%
Hang Seng Hong Kong
27.36%
1.06
25.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-8.57%
EBIT Growth (5y)
-18.10%
EBIT to Interest (avg)
41.99
Debt to EBITDA (avg)
0.17
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
23.53
Tax Ratio
33.66%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.12%
ROE (avg)
14.77%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
24
Industry P/E
Price to Book Value
1.64
EV to EBIT
16.95
EV to EBITDA
13.00
EV to Capital Employed
1.66
EV to Sales
2.61
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.80%
ROE (Latest)
6.86%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Guanze Medical Information Industry (Holding) Co., Ltd.
Net Sales
Highest at HKD 125.52 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (HKD MM)

Net Sales
At HKD 125.52 MM has Grown at 42.29%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (HKD MM)

Net Profit
Highest at HKD 18.84 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (HKD MM)

EPS
Highest at HKD 0.02
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (HKD)

Depreciation
Highest at HKD 4.31 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation
At HKD 4.31 MM has Grown at 20.56%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for Guanze Medical Information Industry (Holding) Co., Ltd.
Raw Material Cost
Grown by 33.53% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales